Inventor · disambiguated record
Ulrich Brinkmann
Also filed as: BRINKMANN ULRICH
51 granted patents·58 pending applications·912 citations·filing 1993–2025
98Inventor score
Top patents by PatentIndex Score
109 records- 0197US9382323B2Multispecific antibodies comprising full length antibodies and single chain fab fragmentsBRINKMANN ULRICH·Filed 2010·Granted Jul 5, 2016·77 cites·22 claims
- 0297US8268314B2Bispecific anti-VEGF/anti-ANG-2 antibodiesBAEHNER MONIKA·Filed 2009·Granted Sep 18, 2012·70 cites·18 claims
- 0396US6558672B1Methods of making recombinant disulfide-stabilized polypeptide fragments having binding specificityUS HEALTH·Filed 2000·Granted May 6, 2003·68 cites·2 claims
- 0495US8133979B2Antibodies against human angiopoietin 2BRINKMANN ULRICH·Filed 2009·Granted Mar 13, 2012·19 cites·10 claims
- 0595US5747654ARecombinant disulfide-stabilized polypeptide fragments having binding specificityUS HEALTH·Filed 1993·Granted May 5, 1998·140 cites·27 claims
- 0694US9890204B2Trivalent, bispecific antibodiesBRINKMANN ULRICH·Filed 2012·Granted Feb 13, 2018·27 cites·11 claims
- 0794US8703130B2Bispecific anti-VEGF/anti-ANG-2 antibodiesBAEHNER MONIKA·Filed 2012·Granted Apr 22, 2014·23 cites·12 claims
- 0894US5608039ASingle chain B3 antibody fusion proteins and their usesUS HEALTH·Filed 1994·Granted Mar 4, 1997·163 cites·18 claims
- 0992US10633457B2Multispecific antibodiesHOFFMANN LA ROCHE·Filed 2017·Granted Apr 28, 2020·6 cites·7 claims
- 1092US9708396B2Bispecific anti-VEGF/anti-ANG-2 antibodiesHOFFMANN LA ROCHE·Filed 2014·Granted Jul 18, 2017·16 cites·17 claims
- 1192US8361747B2Antibodies against human angiopoietin 2HOFFMANN LA ROCHE·Filed 2012·Granted Jan 29, 2013·10 cites·4 claims
- 1291US9388222B2Modified Pseudomonas exotoxin AUS HEALTH·Filed 2014·Granted Jul 12, 2016·15 cites·42 claims
- 1391US8399626B2Antibodies against human angiopoietin 2BRINKMANN ULRICH·Filed 2012·Granted Mar 19, 2013·9 cites·5 claims
- 1489US10806795B2Bispecific anti-hapten/anti-blood brain barrier receptor antibodies, complexes thereof and their use as blood brain barrier shuttlesHOFFMANN LA ROCHE·Filed 2019·Granted Oct 20, 2020·3 cites·17 claims
- 1587US9765153B2Anti-biotin antibodies and methods of useHOFFMANN LA ROCHE·Filed 2014·Granted Sep 19, 2017·7 cites·20 claims
- 1687US8907069B2Complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agentBRINKMANN ULRICH·Filed 2010·Granted Dec 9, 2014·7 cites·17 claims
- 1787US2023227543A1Antibodies against human angiopoietin 2HOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1886US9303076B2Cell-penetrating peptides and uses thereofHOFFMANN LA ROCHE·Filed 2015·Granted Apr 5, 2016·7 cites·12 claims
- 1986US9303075B2Cell-penetrating peptides and uses thereofHOFFMANN LA ROCHE·Filed 2012·Granted Apr 5, 2016·10 cites·29 claims
- 2085US11273223B2Bispecific anti-hapten/anti-blood brain barrier receptor antibodies, complexes thereof and their use as blood brain barrier shuttlesHOFFMANN LA ROCHE·Filed 2020·Granted Mar 15, 2022·1 cites·28 claims
- 2185US6147203ARecombinant disulfide-stabilized polypeptide fragments having binding specificityUS HEALTH·Filed 1998·Granted Nov 14, 2000·70 cites·8 claims
- 2284US9879095B2Bispecific antibodies comprising a disulfide stabilized-Fv fragmentHOFFMANN LA ROCHE·Filed 2013·Granted Jan 30, 2018·5 cites·19 claims
- 2384US9340609B2Antibodies against human angiopoietin 2HOFFMANN LA ROCHE·Filed 2012·Granted May 17, 2016·3 cites·5 claims
- 2484US2023399391A1Bispecific anti-vegf/anti-ang-2 antibodiesHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 2582US10561737B2Bispecific anti-hapten/anti-blood brain barrier receptor antibodies, complexes thereof and their use as blood brain barrier shuttlesHOFFMANN LA ROCHE·Filed 2014·Granted Feb 18, 2020·4 cites·17 claims
- 2682US9050375B2Bi-specific digoxigenin binding antibodiesBRAMLAGE BIRGIT·Filed 2010·Granted Jun 9, 2015·6 cites·17 claims
- 2782US7052703B1T-cell receptorγ alternate reading frame protein, (TARP) and uses thereofUS HEALTH·Filed 2000·Granted May 30, 2006·9 cites·31 claims
- 2881US9109027B2Antibodies against human angiopoietin 2BRINKMANN ULRICH·Filed 2012·Granted Aug 18, 2015·2 cites·2 claims
- 2980US2020262904A1Antibodies against human angiopoietin 2HOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 3078US12180279B2Method for in vivo generation of multispecific antibodies from monospecific antibodiesHOFFMANN LA ROCHE·Filed 2020·Granted Dec 31, 2024·1 cites·18 claims
- 3178US10517945B2Covalently linked antigen-antibody conjugatesHOFFMANN LA ROCHE·Filed 2014·Granted Dec 31, 2019·3 cites·16 claims
- 3278US9925272B2Anti-theophylline antibodies and methods of useHOFFMANN LA ROCHE·Filed 2014·Granted Mar 27, 2018·3 cites·15 claims
- 3378US2021388071A1Antibodies against human angiopoietin 2HOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 3477US10519249B2Covalently linked polypeptide toxin-antibody conjugatesHOFFMANN LA ROCHE·Filed 2016·Granted Dec 31, 2019·2 cites·8 claims
- 3577US5759782ACellular apoptosis susceptibility protein (CSP) and antisense CSPUS HEALTH·Filed 1995·Granted Jun 2, 1998·21 cites·14 claims
- 3676US10106600B2Bispecific antibodiesBRINKMANN ULRICH·Filed 2011·Granted Oct 23, 2018·2 cites·11 claims
- 3776US2024043564A1Anti-brdu antibodies and methods of useHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 3875US10407511B2Covalently linked helicar-anti-helicar antibody conjugates and uses thereofHOFFMANN LA ROCHE·Filed 2016·Granted Sep 10, 2019·2 cites·9 claims
- 3974US6723508B2Method for determining the presence of at least one allele of a GSTT1 deletion mutantEPIDAUROS BIOTECHNOLOGIE AG·Filed 2001·Granted Apr 20, 2004·14 cites·1 claims
- 4074US5990296ASingle chain B3 antibody fusion proteins and their usesUS HEALTH·Filed 1996·Granted Nov 23, 1999·37 cites·2 claims
- 4173US2025361326A1Method for generating multispecific antibodies from monospecific antibodiesHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 4272US11673968B2Anti-BRDU antibodies and methods of useHOFFMANN LA ROCHE·Filed 2019·Granted Jun 13, 2023·0 cites·3 claims
- 4372US2021047394A1Bispecific anti-vegf/anti-ang-2 antibodiesHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 4472US2025206821A1Method for in vivo generation of multispecific antibodies from monospecific antibodiesHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 4571US2025250559A1Method to analyze and optimize gene editing modules and delivery approachesHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 4670US11993642B2Trivalent, bispecific antibodiesHOFFMANN LA ROCHE·Filed 2019·Granted May 28, 2024·0 cites·10 claims
- 4769US2024158533A1Trifab-contorsbodyHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 4869US2025361325A1Method for generating multispecific antibodies from monospecific antibodiesHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 4969US2018282404A1Antibodies against human angiopoietin 2HOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 5067US9574016B2Complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agentHOFFMANN LA ROCHE·Filed 2014·Granted Feb 21, 2017·0 cites·8 claims
Showing the top 50 of 109 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Ulrich Brinkmann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →